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licenses/by-nc-nd/3.0/).AIM: To develop and validate a simple, reproducible method to assess dural sac size using
standard imaging technology.
MATERIALS AND METHODS: This study was institutional review board-approved. Two
readers, blinded to the diagnoses, measured anterioreposterior (AP) and transverse (TR) dural
sac diameter (DSD), and AP vertebral body diameter (VBD) of the lumbar vertebrae using MRI
images from 53 control patients with pre-existing MRI examinations, 19 prospectively MRI-
imaged healthy controls, and 24 patients with Marfan syndrome with prior MRI or CT lum-
bar spine imaging. Statistical analysis utilized linear and logistic regression, Pearson correla-
tion, and receiver operating characteristic (ROC) curves.
RESULTS: AP-DSD and TR-DSD measurements were reproducible between two readers
(r ¼ 0.91 and 0.87, respectively). DSD (L1eL5) was not different between male and female
controls in the AP or TR plane (p ¼ 0.43; p ¼ 0.40, respectively), and did not vary by age
(p ¼ 0.62; p ¼ 0.25) or height (p ¼ 0.64; p ¼ 0.32). AP-VBD was greater in males versus females
(p¼ 1.5 108), resulting in a smaller dural sac ratio (DSR) (DSD/VBD) in males (p¼ 5.8 106).
Marfan patients had larger AP-DSDs and TR-DSDs than controls (p ¼ 5.9  109; p ¼ 6.5  109,
respectively). Compared to DSR, AP-DSD and TR-DSD better discriminate Marfan from control
subjects based on area under the curve (AUC) values from unadjusted ROCs (AP-DSD p < 0.01;
TR-DSD p ¼ 0.04).
CONCLUSION: Individual vertebrae and L1eL5 (average) AP-DSD and TR-DSD measurements
are simple, reliable, and reproducible for quantitating dural sac size without needing to control
for gender, age, or height.
 2014 The Royal College of Radiologists. Published by Elsevier Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Patients with heritable connective tissues disorders
(HCTD), such as Marfan syndrome, EhlerseDanlosls, 7019 Thurston-Bowles
þ1 919 966 6780; fax: þ1
edu (M.L.A. Daniels).
Published by Elsevier Ltd. This is asyndrome (EDS), and LoeyseDietz syndrome (LDS), show
diverse manifestations of disorganized connective tissue
matrices, particularly in the cardiovascular and skeletal
systems. Lung disease in Marfan patients includes apical
blebs and spontaneous pneumothorax, and is included in
the systemic score of the Ghent criteria for Marfan syn-
drome.1 These patients also have an increased frequency of
pneumonia and bronchiectasis.2e8 Although dural ectasia,
dilation of the dural sac surrounding the spinal cord, isn open access article under the CC BY-NC-ND license (http://creativecommons.org/
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speciﬁc and can be seen in LDS and variant EDS.1,12e14 Data
regarding the presence of both dural ectasia and lung ab-
normalities in HCTD patients is limited. In one study,w10%
of 138 Marfan patients had apical blebs or spontaneous
pneumothorax, even though w50% had dural ectasia;
however, it is unclear how many patients had both lung
disease and dural ectasia.15 In another study of 33 patients
with Marfan-like features without mutations in FBN1,
TGFbR1, or TGFbR2, two patients had spontaneous pneu-
mothorax and dural ectasia.16
The present authors have studied dural ectasia in pa-
tients with HCTD and idiopathic bronchiectasis because of
the physical morphological similarities in idiopathic bron-
chiectasis and Marfan patients. However, there is currently
no preferred method for quantiﬁcation of dural sac size in
the literature,10 and a method that has been validated in
normal and diseased subjects is needed. Published methods
of quantitating dural ectasia do not routinely account for
the effects of gender, height, or age. The most widely used
approaches are those published by Oosterhof,17 Haber-
mann,18 Lundby,19 and Ahn.20 The Oosterhof, Habermann,
and Lundby methods rely on a dural sac “ratio” (DSR),
calculated by dividing the lumbar anterioreposterior (AP)
dural sac diameter (DSD) by the AP vertebral body diameter
(VBD), as determined via MRI or CT imaging. All of these
methods also focus on S1 measurements (either DSD or
DSR). Conceptually, S1 should demonstrate robust dural
ectasia in Marfan syndrome, as it is the most caudal and has
the greatest cerebrospinal ﬂuid (CSF) pressures in an up-
right position. However, the S1 vertebra is structurally
different compared with the lumbar vertebrae in several
ways, which may confound measurements. The ﬁve sacral
vertebrae fuse to form the sacrum,21 and the sacral base is
pitched forward, creating the sacrovertebral angle,22 which
progressively increases from 20 at birth to 70 by adult-
hood. Although the sacrum is larger in men,23 none of the
published assessments of DSR account for potential differ-
ences in size of dural sac or vertebral body due to gender,
height, age, or race. This is despite recognition that the AP
diameters, TR diameters, and volumes of all the lumbar
vertebral bodies are smaller inwomen as compared to men,
even when matched for age, height, and weight.24 Cross-
sectional vertebral area is also signiﬁcantly smaller in
women as compared to age-matched men.25,26
The aim of the present study was to develop and validate
a simple, reproducible, standardized method of quanti-
tating dural sac size, and assess for the effects of gender,
height, age, and race by using measurements from a large
healthy control population. Measurements were also per-
formed in a smaller group of Marfan syndrome patients for
comparison.Materials and methods
The local institutional review board approved the pre-
sent study. Informed consent was waived for evaluation of
pre-existing MRI images; informed consent and MRI safetyscreening forms were completed in prospective subjects. All
data were recorded in a Health Insurance Portability and
Accountability Act (HIPAA)-compliant protected database.
Patients
Normal adult (>18 years of age) control subjects (n¼ 53)
who had normal pre-existing MRI examinations of the
lumbo-sacral spine, obtained for clinical purposes, were
used in a retrospective fashion. Normality was determined
by a consensus of the MRI examination report, and re-
review by a radiologist with >10 years of experience. Clin-
ical information from medical records was used to exclude
patients with deﬁnite or possible HCTD, lung disease, or any
spinal disease not recognized on the MRI examination.
Measurements were not made on imaging from these
excluded individuals. Subsequently, healthy adult controls
(n ¼ 19), matched by age and gender to the retrospective
control group, were prospectively enrolled for lumbo-sacral
MRI examinations (Supplementary Material Fig S1). Exclu-
sion criteria for all subjects included severe thoracic or
lumbar scoliosis, thoracic or lumbar spine surgery, spinal
stenosis, or spine injury. Exclusion criteria for the pro-
spectively enrolled healthy controls included: presence of
lung disease; bone or connective tissue disease (including
hypermobility); history of malignancy; endocrine disorder
requiring medication; atopy; chronic or recurrent systemic
steroids; 50 years of age taking prescription medications;
and >50 years of age taking prescription medication except
for hypertension or hyperlipidaemia. An additional 24
subjects carrying a genetic or clinical diagnosis of Marfan
syndrome and had a pre-existing MRI or CT examination of
the lumbo-sacral spine available for measurement were
included for comparison.
Imaging protocol
Both pre-existing and prospective lumbar MRI exami-
nations were performed using a Siemens (Iselin, NJ, USA) 1.5
T Avanto or 3 T Biograph MRI machine. Pre-existing spine
MRI images were generated using a clinical unenhanced
protocol; T2-weighted 5 mm axial and sagittal images were
viewed on an Agfa (Mortsel, Belgium) PACS workstation
using standard Agfa measuring tools and were amenable to
3D manipulation with the Agfa PACS tools. Prospective
scanswere performed using a single unenhanced 7minMRI
sequence [T2-weighted 3-dimensional (3D) turbo spin echo
without fat suppression], which yielded a single 3D-dataset.
From this dataset, 1.5 mm images in the axial, sagittal, and
coronal planes were reconstructed at the scanner work-
station and evaluated on the same Agfa PACS station.
Image analysis
All examinations were reviewed by a board-certiﬁed
radiologist with >10 years of experience (reader 1) and a
second-year medical student (reader 2), both of whomwere
blinded to diagnosis. Reader 2 was trained on measurement
techniques by the radiologist, and completed several prac-
tice cases under supervision before measuring study cases.
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mid-sagittal images were used to measure the AP-VBD
and AP-DSD (Fig 1aeb) from L1 to S1. Axial or
axialeoblique images were used to measure the orthogonal
transverse (TR)-DSD (Fig 1ced). If needed, images were
manipulated with the 3D PACS tool in order to obtain true
orthogonal measurements. Vertebral body and dural sac
measurements were made at the mid-corpus level of the
vertebral body, perpendicular to the long axis of the dural
sac. For the ﬁnal analysis, the S1 vertebral level was
excluded because S1 segments are highly variable in
morphology (described above), resulting in irregular
measures.
Statistical analysis
Beginning with measurements of controls made by
reader 1 (radiologist), linear regression was performed to
compare the effects of covariates, including height, gender,
age, and race on AP-DSD, TR-DSD, and AP-VBD measure-
ments of L1 through L5 and the L1eL5 (average). Scatter
plots were also used to assess the relationship between AP-
DSD and TR-DSD by age and height in females andmales. To
validate the method, separate linear models were
employed, whichwere ﬁt to each control groupwith height,
gender, age, and race as predictor variables, and then
whether the coefﬁcients of the covariates in the twomodels
were signiﬁcantly different using the Bonferroni correction.
Pearson’s correlation was used to calculate the adjusted
and unadjusted correlation between readers 1 and 2 of the
AP-DSD, TR-DSD, and AP-VBD measurements. For the
adjusted correlation, pairwise correlation between re-
siduals in the regression model was used.Figure 1 Sagittal and axial unenhanced T2 weighted 3D-turbo spin echo M
lines) and AP-DSD (red lines) in a healthy control subject (a) and a patieThe combined control group (n ¼ 72) measures of L1eL5
(average) AP-DSD, TR-DSD, and DSR by reader 1 were
compared to patients with Marfan syndrome using linear
regression. For all linear regression analysis, both the un-
adjusted and adjusted models were examined; signiﬁcance
was not changed based on model type. p < 0.05 indicated a
statistically signiﬁcant difference.
AP-DSDs, TR-DSDs, and DSRs were individually included
in a logistic regression model as the sole predictor variable
and diagnosis of Marfan as the outcome to obtain the
receiver operating characteristics (ROC) curves and corre-
sponding area under the curve (AUC). Separate model ﬁts
were also performed with the same variables, after
adjusting for height, age, race, and gender. The unadjusted
logistic regression models were used as these covariates are
not adjusted for in the currently employed methods of
assessing dural sac size. DeLong’s test was used to compare
AUC values. All statistical analysis was performed using
STATA (StataCorp 2011; Stata Statistical Software: release
12, StataCorp, College Station, TX, USA) and R.27
Results
Measurements were initially made in 53 control subjects
(26 female and 27 male subjects; age range 18 to 88 years)
by reader 1 (demographics in Supplementary Material
Table S1a). The AP- and TR-DSD measures for males and
females were similar at each level (L1 to L5), and the
calculated L1eL5 (average) AP- and TR-DSD were not
different between males and females (p ¼ 0.43 and 0.40;
Supplementary Material Table S2; Table 1). AP-DSD and TR-
DSD did not differ between subjects self-identiﬁed as white
or African-American (p ¼ 0.85 and 0.41), respectively.RI images of the lumbosacral spine. Measurements of AP-VBD (yellow
nt with Marfan’s syndrome (b).
Table 1
L1eL5 (average) anterior-posterior (AP) dural sac diameter (DSD) and
transverse (TR) DSD by gender for initial controls (reader 1).
Female (n ¼ 26) Male (n ¼ 27) p-Value
L1eL5 AP-DSD (cm) 1.38 þ 0.15 1.35 þ 0.12 0.43
L1eL5 TR-DSD (cm) 1.86 þ 0.20 1.89 þ 0.14 0.40
Data are means þ standard deviation.
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gender in the model, demonstrated no variation in AP-DSD
and TR-DSD by age (p ¼ 0.62 and 0.25) or height (p ¼ 0.64
and 0.32), respectively (Supplementary Material Fig S2).
To validate the method, it was applied to 19 prospec-
tively imaged control subjects (nine females and 10 males;
demographics in Supplementary Material Table S1b). Again,
no difference was found in the AP- and TR-DSD measure-
ments between males and females at each level (L1 to L5)
and for the calculated L1eL5 (average) (Supplementary
Material Table S3). Bonferroni correction was used to test
for a difference between the coefﬁcients of the covariates
from each control group’s model, which included height,
gender, age, and race as predictor variables. L1eL5 (average)
AP-DSD (p ¼ 0.81) and TR-DSD (p ¼ 0.37; Table 2; reader 1)
were non-signiﬁcant, as was AP-VBD (p ¼ 0.47; data not
shown), conﬁrming that the two groups are similar (Table 2
and Supplementary Material Table S4).
As AP-DSD and TR-DSD at L1 through L5 did not differ by
gender, height, age, or control group, all control subjects
were combined to plot the L1eL5 (average) AP-DSD and TR-
DSD (95% conﬁdence intervals; Fig 2). As seen in Fig 2,
there is a slight increase in variability in TR-DSD at the more
caudal vertebral levels, but therewas reasonable correlation
between AP-DSD and TR-DSD measurements (r ¼ 0.74)
(Supplementary Material Fig S3).
To substantiate the approach to quantitate AP-DSD, TR-
DSD, and AP-VBD, reader 2 performed the same L1 to L5
measurements in the same 72 subjects in a blinded fashion.
Reader 2 also showed that TR-DSD was larger than AP-DSD
with slightly greater variability at more caudal levels
(Supplementary Material Fig S4). As seen in the plot of all
360 measurements of L1 through L5, there was good cor-
relation between the two readers for AP-DSD (r ¼ 0.91) and
TR-DSD (r ¼ 0.87; Fig 3), as well as AP-VBD (r ¼ 0.91; data
not shown). It is noteworthy that AP-DSD and TR-DSD were
not different in the 10 African-American subjects, compared
to the 56 white subjects (p ¼ 0.46 and 0.67, respectively).
As seen in Supplementary Material Table S4, AP-VBD was
substantially greater in males (p ¼ 1.5  108), which led usTable 2
L1eL5 (average) anterior-posterior (AP) dural sac diameter (DSD) and
transverse (TR) DSD by control subject group (reader 1).
Initial
controls
(n ¼ 53)
Validation
controls
(n ¼ 19)
p-Value All controls
(n ¼ 72)
L1eL5 AP-DSD (cm) 1.37 þ 0.13 1.42 þ 0.18 0.81 1.38 þ 0.15
L1eL5 TR-DSD (cm) 1.88 þ 0.17 1.91 þ 0.18 0.37 1.89 þ 0.17
Data are means þ standard deviation.to explore the relationship between height and VBD. AP-
VBD is positively correlated to height in both males and
females (p ¼ 3.6  105; p ¼ 0.001, respectively). As height
increases, AP-VBD increases in both men and women
(Supplementary Material Fig S5); thus, males are taller than
females (p ¼ 7.5  1012), and AP-VBD is signiﬁcantly larger
in males.
Because previous methods of assessing dural ectasia in
Marfan syndrome used the ratio of AP-DSD to AP-VBD, DSRs
between control males and females were examined. VBDs
(AP) are signiﬁcantly larger in males, whereas DSDs (AP)
show no difference between genders (Supplementary
Material Table S4; Table 1); therefore, the ratios are strik-
ingly smaller in males versus females (p ¼ 5.8  106). This
clearly demonstrates that “ratios” distort the assessment of
dural sac size in males versus females, and between in-
dividuals of different heights; therefore, direct measure-
ments of AP-DSD are most accurate to deﬁne the size of the
dural sac.
The same methods of measuring dural sac size were
applied to 24 subjects with Marfan syndrome (de-
mographics in SupplementaryMaterial Table S5a); again, we
noted good reader agreement (AP-DSD r ¼ 0.85; TR-DSD
r ¼ 0.90; AP-VBD r ¼ 0.87). As seen in controls, there was
no difference in L1eL5 (average) DSD between males and
females withMarfan syndrome in both the AP and TR planes
(p ¼ 0.59 and 0.83, respectively; Supplementary Material
Table S5b). The 24 Marfan patients were then compared to
the 72 control subjects. Marfan subjects (males and females
combined) have signiﬁcantly larger L1eL5 (average) AP-DSD
and TR-DSD measurements, as compared to control subjects
(p¼ 5.9 109 and 6.5109, respectively; Table 3). Similar
to control subjects, Marfan males tend to have larger L1eL5
(average) AP-VBD and DSR measures as compared to Marfan
females (p ¼ 0.03 and 0.06 respectively; Supplementary
Material Table S5b). When the control and Marfan subjects
were compared by gender, L1eL5 (average) DSR is signiﬁ-
cantly larger in Marfan males versus control males
(p ¼ 8.2  105), but there was no signiﬁcant difference in
L1eL5 (average) DSR between Marfan females and control
females (p ¼ 0.07; Table 3). These results again demonstrate
that using “ratios” distort the assessment of dural sac size in
males versus females. AP-DSD alone gives a much more
robust difference (p ¼ 5.9  109) than DSR (p ¼ 0.001)
between controls and Marfan subjects, when gender is not
considered. Further evidence demonstrating the superiority
of AP-DSD and TR-DSDmeasures over DSR is seen in the AUC
values calculated from the unadjusted logistic regression
model ROCs. L1 through L5 and L1eL5 (average) AP-DSD and
TR-DSD have signiﬁcantly higher AUC values as compared to
DSR (AP-DSD p < 0.01; TR-DSD p ¼ 0.04; Table 4; Fig 4).Discussion
The present authors have studied dural ectasia in pa-
tients with HCTD and idiopathic bronchiectasis because of
physical morphological similarities in idiopathic bronchi-
ectasis and Marfan patients. Prior published methods to
Figure 2 Mean and 95% conﬁdence intervals of AP-DSD and TR-DSD at L1 through L5 in 72 control subjects (reader 1). (a) Mean AP-DSD
diameter decreases in size moving caudally through the lumbar spine. Variability in AP-DSD is small and does not vary by vertebral level. (b)
Mean TR-DSD diameter decreases in size moving caudally through the lumbar spine and variability increases slightly increases.
Figure 3 Correlation of reader 1 and 2 measurements for AP-DSD and TR-DSD of L1 through L5. Graphs show correlation of measurements
between reader 1 and reader 2 for all measures from L1 through L5. (a) Pearson correlation coefﬁcient for all measures of AP-DSD ¼ 0.91
(p < 0.01). (b) Pearson correlation coefﬁcient for all measures of TR-DSD ¼ 0.87 (p < 0.01). Degree of correlation varies by vertebral level.
M.L.A. Daniels et al. / Clinical Radiology 70 (2015) 146e152150quantitate dural sac size have not been standardized to
address comparisons by gender, age, and height.17e20
Therefore, the present study was undertaken to develop a
simple method of assessing dural sac size that could beTable 3
Measurements of L1eL5 (average) for anterior-posterior (AP) dural sac
diameter (DSD) and transverse (TR) DSD, AP-vertebral body diameter (VBD),
and calculated dural sac ratio (DSR) in controls and Marfan patients (reader
1).
Control (n ¼ 72)
Female ¼ 35
Male ¼ 37
Marfan (n ¼ 24)
Female ¼ 10
Male ¼ 14
p-Value
AP-DSD (cm) Female &
male
1.38 þ 0.15 1.61 þ 0.17 5.9  109
TR-DSD (cm) Female &
male
1.89 þ 0.17 2.22 þ 0.32 6.5  109
AP-VBD (cm) Female 2.78 þ 0.21 2.91 þ 0.19
Male 3.11 þ 0.23 3.14 þ 0.25
DSR
(AP-DSD/
AP-VBD)
Female 0.51 þ 0.08 0.56 þ 0.06 0.07
Male 0.44 þ 0.05 0.51 þ 0.06 8.2  105
Data are means þ standard deviation.replicated in a variety of patient types by investigators with
varying experience using readily available imaging tech-
nology. The present systematic approach involved two in-
dependent readers who undertook blinded measurements
in two normal (control) groups: those with previously ob-
tained MRI images (n ¼ 53) and those prospectively imaged
(n ¼ 19). The method was validated using measures of AP-
DSD and TR-DSD to assess dural sac size, and established
normal reference values. These measures are easilyTable 4
Unadjusted AUC values of individual vertebral levels and L1eL5 (average) for
anterior-posterior (AP) dural sac diameter (DSD) and transverse (TR) DSD,
and dural sac ratio (DSR) for determining Marfan diagnosis (reader 1).
L1 L2 L3 L4 L5 L1eL5 (average)
AP-DSD 0.68 0.8 0.85 0.81 0.86 0.86a
TR-DSD 0.71 0.74 0.79 0.82 0.86 0.84b
DSR 0.56 0.67 0.74 0.69 0.79 0.73
No signiﬁcant difference between AUC values of L1eL5 (average) AP-DSD
and TR-DSD (p ¼ 0.51).
a p < 0.01 as compared to DSR.
b p ¼ 0.04 as compared to DSR.
Figure 4 Unadjusted ROC curves of L1eL5 (average) AP-DSD, TR-DSD,
and DSR (reader 1). L1eL5 (average) AP-DSD (blue; p < 0.01) and TR-
DSD (red; p ¼ 0.04) discriminate Marfan from control subjects better
than L1eL5 (average) DSR (green). ROC curves are unadjusted for
gender, age, height, and race.
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reproducible by readers of different experience, and are not
inﬂuenced by age, gender, height, or race.
Prior methods of assessing dural sac size have largely
relied upon DSR, which is the AP-DSD divided by the AP-
VBD. Age-related declines in vertebral body height corre-
spond to an increase in AP-VBD and TR-VBD size, con-
founding the use of DSR to assess dural sac size.28,29 The
present study demonstrates that DSR is ﬂawed for com-
parisons between subjects of different heights, because
vertebral body sizes vary by height in both genders, a
ﬁnding reported previously.24,30 Females are shorter than
males, and have larger DSRs, which can lead to erroneous
classiﬁcation of dural sac size if gender, height, and age are
not considered. The robust discriminatory power of AP-DSD
measurements in the lumbar spine as compared to DSR is
seen in the magnitude of the p-value (p ¼ 5.9  109 vs
0.001) when comparing all Marfan subjects to all control
subjects, the lack of a detectable difference in L1eL5
(average) DSR betweenMarfan females and control females,
and the signiﬁcantly higher AUC value (p < 0.01). DSR
clearly distorts the assessment of dural sac size due to
gender, height, and age factors; therefore, direct measure-
ments of AP-DSD alone are most accurate.
Published methods about dural sac size in Marfan sub-
jects have focused heavily on themeasurements obtained at
the S1 level, because in these patients, dural ectasia is most
pronounced at and below the S1 vertebral level (Fig 1b).
Although this is well-substantiated in the Marfanpopulation, this observation may not apply to non-Marfan
subjects. The substantial structural variability of the S1
vertebra between genders and individuals results in highly
variable measures, even in normal subjects. Further, DSD is
signiﬁcantly larger at all lumbar vertebral levels in Marfan
patients in both the AP and TR plane, as compared to non-
Marfan subjects, which obviates the need to assess dural
sac size at the highly variable S1 vertebral level.
One limitation of the present study is the smaller number
of validation subjects. A volume measurement to further
validate the method was not used due to the skill required
and lack of universally available software to quantitate vol-
umes. For a small number of Marfan patients without avail-
able MRI images, CT images were used, which have a lower
soft-tissue contrast resolution and may have a blooming
artefact from bone. However, there are studies validating
bothCTandMRI.20,31,32 Additionally, pre-existingMRI images
used a 5 mm section thickness, whereas prospective scans
used a 1.5 mm section thickness. Although the Marfan group
had a larger proportion of African-American patients as
compared to the control group, this likely did not inﬂuence
the present ﬁndings, as there was no difference in the AP-
DSDs or TR-DSDs in the African-Americans studied.
In summary, individual lumbar vertebral AP-DSD mea-
surement is a simple, reliable, and reproducible method of
assessing dural sac size without potential confounding
variability from gender, height, age, or race.Acknowledgements
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